EZH2 and adrenal cortex carcinoma: We have also shown that EZH2 overexpression was associated with tumour progression and poor prognosis in ACC8 in agreement with other cancers.9 Overexpression of EZH2 in ACC patients was also consistent with the high expression of EZH2 detected in AdTAg mice during tumour progression.4